Note 18 - Revenue - Revenues (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Deferred revenue | $ 13 | $ 0 |
| Increases due to consideration received from customers | 759 | 28 |
| Revenue recognized | (771) | (15) |
| Deferred revenue | 249 | 13 |
| Evoke Neuroscience, Inc. [Member] | ||
| Acquired in Evoke business combination | $ 248 | $ 0 |
| X | ||||||||||
- Definition Consideration received from contract with customer. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|